Sun Pharma Baska facility gets OAI status from USFDA

Mumbai:  Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and Drug Administration (USFDA) for Baska facility.

The USFDA conducted an inspection at the facility from 8 September 2025 to 19 September 2025.

OAI means regulatory and/or administrative actions are recommended.

“We continue to manufacture and supply approved products from the facility to the US market. We will work with the regulator to achieve fully compliant status,” the company stated in a BSE filing.

Sun Pharma is a specialty generics company with a presence in specialty, generics and consumer healthcare products. Sun Pharma’s global specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. Its manufacturing facilities are spread across six continents.

Related Posts

India curbs supply of IVF consumables to unregistered clinics

The move comes amid growing concerns over the proliferation of fertility centres in India, one of the world’s fastest-growing IVF markets. New Delhi: India is moving to cut off supplies…

Maha FDA seizes counterfeit skincare products; FIR registered

Pune: The Food and Drug Administration (FDA), Maharashtra, has seized 12 counterfeit bottles of the popular skincare product Cetaphil Gentle Skin Cleanser from a retailer in Shivajinagar. The incident took…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India curbs supply of IVF consumables to unregistered clinics

India curbs supply of IVF consumables to unregistered clinics

Maha FDA seizes counterfeit skincare products; FIR registered

Maha FDA seizes counterfeit skincare products; FIR registered

RMSCL MD Inspects Rajasthan Sampark Portal; Directs Prompt Resolution of Medicine-Related Grievances

RMSCL MD Inspects Rajasthan Sampark Portal; Directs Prompt Resolution of Medicine-Related Grievances

4 arrested in blood plasma adulteration racket

4 arrested in blood plasma adulteration racket

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions